Biotech startup Adela procures $60m in Series A financing

Toronto-based biotechnology startup Adela has launched with a $60 million Series A financing. F-Prime led the round, with participation from OrbiMed, Deerfield Management, Decheng Capital and RA Capital Management.

ByIris Dorbian

23 June 2021•5 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Canada North America US Technology Briefs

Biotech startup Adela procures $60m in Series A financing

Decheng Capital

Deerfield

F-Prime Capital

OrbiMed Advisors

RA Capital

Related articles